Author: David Servan-Schreiber
Publisher: Viking Adult
Keywords: life, way, new, anticancer
Number of Pages: 304
Published: 2008-09-04
List price: $25.95
ISBN-10: 0670020346
ISBN-13: 9780670020348

The New York Times bestseller takes us on an empowering journey and changes the way we think about fighting cancer David Servan-Schreiber’s story of his journey from cancer patient to health combines memoir with a clear scientific explanation of what makes cancer cells thrive and what inhibits them. Anticancer is filled with easy to understand charts and diagrams and a sixteen-page color "Anticancer Action" insert that enables readers to make small but essential changes in lifestyle and diet. Your body knows how to fight cancer, says Servan-Schreiber, and you have to help it with nutriti

Author: David E. Thurston
Publisher: CRC Press
Keywords: drugs, anticancer, pharmacology, chemistry
Number of Pages: 312
Published: 2006-11-22
List price: $184.95
ISBN-10: 0849392195
ISBN-13: 9780849392191

While drug therapies developed in the last 50 years have markedly improved the management of some types of cancers, treatment outcomes, and drug side-effects for the most common types remain unacceptable.  However, recent technological advances are leading to improved therapies based on targeting distinct biological pathways in cancer cells. Chemistry and Pharmacology of Anticancer Drugs is a comprehensive survey of all families of anticancer agents currently in use or in advanced stages of clinical trials, including biologicals. The book is unique in providing molecular structures for a

Author: MD, PhD, David Servan-Schreiber
Publisher: Viking Adult
Keywords: new, life, way, anticancer
Number of Pages: 288
Published: 2009-12-31
List price: $26.95
ISBN-10: 0670021644
ISBN-13: 9780670021642

Authors:Milan Potmesil, Herbert M. Pinedo,
Publisher: CRC Press
Keywords: agents, anticancer, new, camptothecins
Number of Pages: 158
Published: 1994-12-19
List price: $219.95
ISBN-10: 0849347645
ISBN-13: 9780849347641

This exciting new book presents the first comprehensive overview of clinical trials of camptothecins, a new class of anticancer agents. Camptothecins are synthetic and semisynthetic derivatives of a plant alkaloid that inhibit a cellular enzyme and trigger a cascade of events leading to programmed cell death. Special attention is given to the adverse effects of camptothecin treatment, as well as to prevention and control. The book boasts contributions by some of the most respected authorities in camptothecin research, who haveoConducted much of the pre-clinical work which helped to renew inter

Authors:Bruce C. Baguley, David J. Kerr,
Publisher: Academic Press
Keywords: development, drug, anticancer
Number of Pages: 397
Published: 2001-10-29
List price: $159.00
ISBN-10: 0120726513
ISBN-13: 9780120726516

Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES:* One work that can be consulted for all aspects of anticancer drug development * Concise

Authors:L. Harivardhan Reddy, Patrick Couvreur,
Publisher: Springer
Keywords: discovery, development, drug, cancer, anticancer, therapeutics, macromolecular
Number of Pages: 500
Published: 2009-11-12
List price: $199.00
ISBN-10: 1441905065
ISBN-13: 9781441905062

In spite of the development of various anticancer drugs, the therapy of cancer has remained challenging for decades. The current therapy of cancer is overwhelmed because of the inability to deliver therapeutics to all regions of a tumor in effective therapeutic concentrations, intrinsic or acquired resistance to the treatment with currently available agents via genetic and epigenetic mechanisms, and toxicity. As a result, cancer therapy using conventional therapeutics and different types of treatment regimens using this therapeutics has not led to a convincing survival benefit of the patients

Authors:William D. Figg, Howard L. McLeod,
Publisher: Humana Press
Keywords: drug, discovery, development, cancer, pharmacodynamics, anticancer, pharmacokinetics, handbook
Number of Pages: 640
Published: 2004-03-26
List price: $225.00
ISBN-10: 1588291774
ISBN-13: 9781588291776

Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap fo